The Center for Global Health R&D Policy Assessment released its latest assessment, “Patent Pools: Assessing Their Value-Added for Global Health Innovation and Access,” which explores the role of joint intellectual property management in global health innovation and access to medicines.
The report’s authors, Amrita Palriwala and Rebecca Goulding, examine two ongoing initiatives, the Medicines Patent Pool and the Pool for Open Innovation against Neglected Tropical Diseases (now WIPO Re:Search), and consider their actual and potential impacts on global health.
Based on these findings, R4D President David di Ferranti and Managing Director Robert Hecht urged more companies to join the Medicines Patent Pool in a recentHuffington Post article, “Can Patent Pools Get More AIDS Drugs to Patients?”
